Skip to content
Healthcare
KZActiveBIN 170840022805
Plans from 2 000 ₸ a month
No entries in risk registers
Registers checked: 18
To risks

ТОО "MLAB"

Director
Асланова Эсмира Джамалкызы
Incorporated
18.08.2017
Address
Алматы ул. КУРМАНГАЗЫ, 96Б
РНН
600900731696

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

0/18

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses and permits

Profile

Summary

Full name
ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "MLAB"
BIN
170840022805
Status
Active
Director
Асланова Эсмира Джамалкызы
Registration date
18.08.2017
Activity
Прочая деятельность в области здравоохранения, не включенная в другие группировки
Legal address
Алматы ул. КУРМАНГАЗЫ, 96Б

In government contracts over 2 years

  • г.Алматы, Алмалинский район, КУРМАНГАЗЫ, 96Б matches the registered one

    contract of 01.10.2026
VAT payer
No, deregistered 27.02.2020
КАТО
751110000
РНН
600900731696
КФС
Собственность предприятий без государственного и иностранного участия
КСЕ
Национальные частные нефинансовые корпорации – ОПП
Company size
Малые предприятия
Employees
от 0 до 5 чел.

Has changed

Procurement role
Поставщик

Activities

1
86909primary

Прочая деятельность в области здравоохранения, не включенная в другие группировки

Download

Contacts

Change history

Financials

Tax payments

6

By year · ₸

2026
222.4K
2025
2.3M-43%
2024
4M+53%
2023
2.6M+81%
2022
1.5M+817%
2021
159.8K
·222.4K
2026year to date
-43%2.3M
2025
+53%4M
2024
+81%2.6M
2023
+817%1.5M
2022
·159.8K
2021
2026
Tax paid222,371 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2025
Tax paid2,320,953 ₸
Penalty0 ₸
Fine27,524 ₸
VAT refund0 ₸
2024
Tax paid4,039,846 ₸
Penalty500 ₸
Fine0 ₸
VAT refund0 ₸
2023
Tax paid2,648,451 ₸
Penalty0 ₸
Fine34,500 ₸
VAT refund0 ₸
2022
Tax paid1,464,618 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2021
Tax paid159,760 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
Estimated taxable profit

Estimate: corporate income tax ÷ 0%. Not a filing and not revenue — the taxable profit implied by the corporate income tax paid. Actual profit differs by deductions, carried-forward losses and reduced rates.

Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

Management & owners

Leadership

2
  • АЭ

    Асланова Эсмира Джамалкызы

    Director

Former directors

  • РГРАХМАНОВА ГУЛЬЗИРА АЛЕКСЕЕВНА
Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Relations & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

ТОО "MLAB" (BIN 170840022805) is an active legal entity in Алматы, registered in 2017 (9 years on the market). Primary activity — прочая деятельность в области здравоохранения, не включенная в другие группировки. Per open government registries as of November 10, 2026: 2 government contracts on Портал государственных закупок РК (goszakup.gov.kz) worth 3,055,000 ₸. Automated screening of open registries found no risk indicators for "MLAB". Director on record — Асланова Эсмира Джамалкызы. Data current as of November 10, 2026.

Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.